RxSight (RXST) Insider Trading & Ownership $46.38 +1.55 (+3.46%) (As of 11/25/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RxSight (NASDAQ:RXST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.36%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$910,786.07Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$29.32 M Get RXST Insider Trade Alerts Want to know when executives and insiders are buying or selling RxSight stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RXST Insider Buying and Selling by Quarter Ad Investors Alley140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.Click now to learn how to have the chance at 140% yields before time runs out! RxSight Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Ilya GoldshlegerInsiderSell3,100$45.00$139,500.00 11/15/2024Ilya GoldshlegerInsiderSell4,875$46.00$224,250.00 11/12/2024Ilya GoldshlegerInsiderSell1,330$46.13$61,352.90 11/12/2024Jesse Anderson CorleyDirectorBuy11,111$45.37$504,106.07 10/30/2024Ilya GoldshlegerInsiderSell3,105$51.91$161,180.55 10/28/2024Ilya GoldshlegerInsiderSell3,100$50.64$156,984.00 DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late!10/25/2024Ilya GoldshlegerInsiderSell3,100$49.79$154,349.00 10/22/2024Ilya GoldshlegerInsiderSell3,100$49.68$154,008.00 10/18/2024Ilya GoldshlegerInsiderSell3,105$50.09$155,529.45 10/16/2024Ilya GoldshlegerInsiderSell3,100$49.78$154,318.00 10/14/2024Ilya GoldshlegerInsiderSell3,100$50.09$155,279.00 10/11/2024Ilya GoldshlegerInsiderSell3,100$50.19$155,589.00 10/8/2024Ilya GoldshlegerInsiderSell3,100$48.26$149,606.00 10/4/2024Ilya GoldshlegerInsiderSell3,100$48.01$148,831.00 9/30/2024Ilya GoldshlegerInsiderSell3,100$49.02$151,962.00 9/26/2024Ilya GoldshlegerInsiderSell3,105$49.29$153,045.45 9/23/2024Ilya GoldshlegerInsiderSell3,100$52.67$163,277.00 9/20/2024Ilya GoldshlegerInsiderSell3,100$53.19$164,889.00 8/5/2024Ilya GoldshlegerInsiderSell9,000$39.25$353,250.00 7/1/2024Shelley B ThunenCFOSell10,000$58.61$586,100.00 6/14/2024Julie AndrewsDirectorSell15,625$58.00$906,250.00 5/3/2024Ronald M Md KurtzCEOSell40,000$60.15$2,406,000.00 5/1/2024Shelley B ThunenCFOSell10,000$52.69$526,900.00 4/1/2024Shelley B ThunenCFOSell20,000$49.90$998,000.00 3/1/2024Shelley B ThunenCFOSell10,000$56.37$563,700.00 2/14/2024Bakker Juliet TammenomsDirectorBuy4,000$51.29$205,160.00 2/12/2024Bakker Juliet TammenomsDirectorBuy4,000$50.38$201,520.00 2/9/2024Ilya GoldshlegerCOOSell10,365$50.74$525,920.10 2/5/2024Shelley B ThunenCFOSell9,125$47.02$429,057.50 2/1/2024Eric WeinbergInsiderSell10,000$50.00$500,000.00 2/1/2024Ilya GoldshlegerCOOSell7,129$49.29$351,388.41 2/1/2024William J Phd LinkDirectorSell28,250$49.67$1,403,177.50 1/26/2024Shelley B ThunenCFOSell31,772$47.11$1,496,778.92 1/22/2024Eric WeinbergInsiderSell10,000$48.00$480,000.00 1/22/2024Ilya GoldshlegerCOOSell5,000$48.00$240,000.00 1/18/2024Shweta ManiarDirectorSell6,399$45.72$292,562.28 1/8/2024Eric WeinbergInsiderSell10,000$42.00$420,000.00 1/8/2024Ilya GoldshlegerCOOSell15,000$43.33$649,950.00 1/8/2024Robert Keith WarnerDirectorSell23,750$42.69$1,013,887.50 1/8/2024Ronald M Md KurtzCEOSell62,500$44.25$2,765,625.00 DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late!12/27/2023Ronald M Md KurtzCEOSell22,500$41.09$924,525.00 12/22/2023Eric WeinbergInsiderSell1,285$40.00$51,400.00 12/22/2023Ilya GoldshlegerCOOSell5,000$40.00$200,000.00 12/18/2023Ilya GoldshlegerCOOSell10,937$39.02$426,761.74 12/15/2023Eric WeinbergInsiderSell8,715$40.01$348,687.15 12/15/2023Shelley B ThunenCFOSell20,000$39.35$787,000.00 12/14/2023Jesse Anderson CorleyDirectorSell12,000$40.12$481,440.00 12/14/2023Ronald M Md KurtzCEOSell40,000$39.70$1,588,000.00 12/11/2023Robert Keith WarnerDirectorSell5,498$35.08$192,869.84 12/8/2023Robert Keith WarnerDirectorSell14,502$35.01$507,715.02 11/28/2023Bakker Juliet TammenomsDirectorSell145,068$29.62$4,296,914.16 (Data available from 1/1/2013 forward) RXST Insider Trading Activity - Frequently Asked Questions Who is on RxSight's Insider Roster? The list of insiders at RxSight includes Bakker Juliet Tammenoms, Eric Weinberg, Ilya Goldshleger, Jesse Anderson Corley, Julie Andrews, Robert Keith Warner, Ronald M Md Kurtz, Shelley B Thunen, Shweta Maniar, and William J Phd Link. Learn more on insiders at RXST. What percentage of RxSight stock is owned by insiders? 9.36% of RxSight stock is owned by insiders. Learn more on RXST's insider holdings. Which RxSight insiders have been buying company stock? The following insiders have purchased RXST shares in the last 24 months: Bakker Juliet Tammenoms ($6,406,680.00), and Jesse Anderson Corley ($504,106.07). How much insider buying is happening at RxSight? Insiders have purchased a total of 499,111 RXST shares in the last 24 months for a total of $6,910,786.07 bought. Which RxSight insiders have been selling company stock? The following insiders have sold RXST shares in the last 24 months: Bakker Juliet Tammenoms ($8,729,163.40), Eric Weinberg ($1,800,087.15), Ilya Goldshleger ($5,351,220.60), Jesse Anderson Corley ($481,440.00), Julie Andrews ($906,250.00), Robert Keith Warner ($1,714,472.36), Ronald M Md Kurtz ($7,684,150.00), Shelley B Thunen ($5,387,536.42), Shweta Maniar ($412,995.80), and William J Phd Link ($1,403,177.50). How much insider selling is happening at RxSight? Insiders have sold a total of 844,041 RxSight shares in the last 24 months for a total of $33,870,493.23 sold. RxSight Key ExecutivesDr. Ronald M. Kurtz M.D. (Age 61)President, CEO & Director Compensation: $1.21MMs. Shelley B. Thunen (Age 70)Chief Financial Officer Compensation: $762.22k1 recent tradesDr. Ilya Goldshleger Ph.D. (Age 49)Chief Operating Officer Compensation: $761.46kMr. Eric J. Weinberg (Age 63)Chief Commercial Officer Compensation: $762.74kMs. Rebecca WillistonVice President of Accounting & FinanceMr. Matt Haller Ph.D.Chief Technology OfficerMr. Oliver MoravcevicVice President of Investor RelationsMr. Roy FreemanVice President of MarketingMs. Caroline VaughnVice President of Human ResourcesMr. Scott GainesSenior VP of Commercial Operations & Business Process More Insider Trading Tools from MarketBeat Related Companies Bausch + Lomb Insider Trades Inspire Medical Systems Insider Trades PROCEPT BioRobotics Insider Trades Envista Insider Trades Axonics Insider Trades Inari Medical Insider Trades LivaNova Insider Trades Enovis Insider Trades TransMedics Group Insider Trades iRhythm Technologies Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:RXST) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMUST-SEE: Everyone will be talking about this $2 trillion AI tech boom soonAmazon is making its biggest investment ever… $150 billion to be exact. And one company stands to benefit...Banyan Hill Publishing | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.